RBC and WBC fatty acid composition following consumption of an omega 3 supplement: lessons for future clinical trials.
Witte
Theodore R
TR
Department of Biochemistry and Microbiology, Marshall University School of Medicine, Huntington, West Virginia, USA. hardmanw@marshall.edu
Salazar
Alexander J
AJ
Ballester
Oscar F
OF
Hardman
W Elaine
WE
D002986:Clinical Trials as Topic; D019587:Dietary Supplements; D018450:Disease Progression; D004912:Erythrocytes / Q000166:cytology*; D005227:Fatty Acids / Q000737:chemistry / Q000378:metabolism*; D015525:Fatty Acids, Omega-3 / Q000378:metabolism*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D007962:Leukocytes / Q000166:cytology*; D008055:Lipids / Q000737:chemistry; D016328:NF-kappa B / Q000096:biosynthesis*; D010865:Pilot Projects
D005227:Fatty Acids; D015525:Fatty Acids, Omega-3; D008055:Lipids; D016328:NF-kappa B